Phase I study of liposome irinotecan (PEP02) in combination with weekly infusion of 5-FU/LV in advanced solid tumors.

医学 伊立替康 不利影响 药代动力学 内科学 活性代谢物 氟尿嘧啶 胃肠病学 药理学 化疗 泌尿科 癌症 结直肠癌
作者
L. Chen,Her‐Shyong Shiah,Ting-Ting Chao,Ruey-Kuen Hsieh,G. Chen,J. Chang,Grace Chao Yeh
出处
期刊:Journal of Clinical Oncology [Lippincott Williams & Wilkins]
卷期号:28 (15_suppl): e13024-e13024 被引量:14
标识
DOI:10.1200/jco.2010.28.15_suppl.e13024
摘要

e13024 Background: PEP02 is a novel nanoparticle liposome formulation of irinotecan (CPT-11) that has improved PK and tumor biodistribution of CPT-11 and its active metabolite-SN38 with encouraging safety and tumor response in preclinical studies and a single-agent phase I study. The study is to define the DLT, MTD, and PK of PEP02 when in combination with high-dose fluorouracil/leucovorin (HDFL) in patients (pt) with advanced solid tumors. Methods: Pts who had failed to standard chemotherapy, ECOG PS 0-1 and adequate organ functions, no prior CPT-11, were eligible. PEP02 was given as 90 mins i.v. infusion on D1 in combination with 24-hr infusion of 5FU (2,000 mg/m2)/ LV (200 mg/m2) on D1 and D8, every 3 weeks. Cohorts of 3-6 pts were treated at 60, 80, 100, and 120 mg/m2. PK and PGx samples were collected. Results: A total of 16 pts were enrolled, with 3, 6, 5, and 2 at 60, 80, 100, and 120 mg/m2. DLTs were observed in 4 pts, including 2 each at 100 and 120 mg/m2 dose levels. DLTs were mainly G3 diarrhea and G4 hematologic toxicities. MTD was determined as 80 mg/m2. Grade 3 or above adverse events at the MTD dose and all dose levels were 10.6% and 18.4%, respectively. The PK of total CPT-11 after PEP02 (at 80 mg/m2) in combination with HDFL was characterized by low clearance (mean = 116.4 mL/m2/hr) and small volume of distribution (mean = 2.93 L/m2, similar to plasma volume) as did of PEP02 monotherapy study. Compared to the PK of SN-38 after 250 mg/m2 of CPT-11 (in combination with capecitabine, Ann Oncol 2005; 16: 1123-32), the Cmax after 80 mg/m2 of PEP02 was lower (7.98 ± 4.39 vs 62.0 ± 37.4 ng/mL), but the AUC0→t was similar (354.77 ± 145.35 vs 396 ± 247 ng×h/mL). The correlation of UGT1A family with PK and toxicity was not observed. However, the only subject with the coexistence of two variants of UGT1A1*6 and *28 had higher dose-normalized AUCSN-38and experienced DLT. The best response of 15 evaluable pts was PR in 2 (gastric cancer and breast cancer) and SD in 9. Conclusions: The MTD of PEP02 in combination with HDFL given every-3-week is 80 mg/m2. The observation of tumor response in two heavily pre-treated patients suggests the combination deserves further exploration in advanced solid tumor patients who are refractory to standard therapy. Author Disclosure Employment or Leadership Position Consultant or Advisory Role Stock Ownership Honoraria Research Funding Expert Testimony Other Remuneration PharmaEngine PharmaEngine PharmaEngine PharmaEngine

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
刚刚
小一点发布了新的文献求助10
刚刚
彪壮的半莲的应助被MOMO采纳,获得10
刚刚
1秒前
yangyang完成签到,获得积分10
1秒前
心灵美天奇完成签到,获得积分10
1秒前
孤独悟空完成签到,获得积分20
4秒前
Aaron发布了新的文献求助10
4秒前
荼蘼发布了新的文献求助10
4秒前
beiwei完成签到 ,获得积分10
5秒前
zzz发布了新的文献求助10
5秒前
q6157完成签到,获得积分10
5秒前
luqi完成签到 ,获得积分10
5秒前
6秒前
FashionBoy的应助被钱都进兜里采纳,获得10
7秒前
8秒前
Czz发布了新的文献求助10
9秒前
9秒前
yl发布了新的文献求助10
9秒前
瘦瘦冬寒完成签到 ,获得积分10
9秒前
9秒前
XD完成签到 ,获得积分10
9秒前
Lucas的应助被壮观海云采纳,获得10
10秒前
栗清歌完成签到,获得积分10
12秒前
卤一碗芋头糕完成签到,获得积分10
12秒前
高兴凝安完成签到 ,获得积分10
12秒前
12秒前
舒适的秋尽完成签到 ,获得积分10
13秒前
学霸业的应助被yu123123采纳,获得10
13秒前
荼蘼发布了新的文献求助10
14秒前
追寻的觅双完成签到 ,获得积分10
14秒前
yuyu完成签到,获得积分10
15秒前
syvshc的应助被府中园马采纳,获得10
16秒前
16秒前
向阳而生完成签到,获得积分10
16秒前
ttttTTTT发布了新的文献求助10
17秒前
包容映安发布了新的文献求助10
17秒前
酷波er的应助被zzz采纳,获得10
18秒前
pyb0919完成签到,获得积分10
20秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
Resource Recovery Handbook 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8175262
求助须知:如何正确求助?哪些是违规求助? 9567017
关于积分的说明 21789663
捐赠科研通 7769695
什么是DOI,文献DOI怎么找? 3431840
关于科研通互助平台的介绍 2556124
邀请新用户注册赠送积分活动 2477241